EBM Technologies Inc

EBM Technologies Inc has a market capitalization of TWD 611.2 million and a price-to-book ratio of 2.12, indicating a moderate premium to its book value. The company holds TWD 144.8 million in cash and equivalents, which is a strong liquidity buffer, but its operating cash flow is negative at TWD -7.3 million, and free cash flow is also negative at TWD -19.3 million. The debt-to-equity ratio is 0.43, suggesting a relatively conservative capital structure. Profitability metrics are concerning, with a return on equity of -7.63% and a return on assets of -4.55%, both significantly below the industry median for advanced medical equipment and technology firms. The company reported a net loss of TWD 21.9 million and an operating loss of TWD 24.4 million, indicating operational inefficiencies or declining demand. The company operates as a single business segment, and its geographic exposure is not disclosed in the available data. However, the lack of segmental or geographic diversification could pose a concentration risk if demand in its primary market declines. Looking ahead, the company is expected to face continued financial pressure, with no clear signs of improvement in the near term. The negative operating and free cash flows suggest that the company may need to rely on its cash reserves to fund operations, which could limit its ability to invest in growth initiatives. Risk factors include the company's negative net income and operating income, which could affect its creditworthiness and access to capital. The risk assessment indicates low liquidity and dilution risk, with no immediate filing-based flags detected. However, the company's negative cash flows and operating losses could increase its exposure to liquidity risk in the future. Recent filings and transcripts do not indicate any major strategic shifts or new product launches. The company's financial performance remains a key area of focus, with no significant events reported in the latest available data.